10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Aciclovir, a nucleoside analogue, is a potent antiviral medication widely used in the treatment of herpes simplex virus (HSV) infections, including oral and genital herpes, as well as varicella-zoster virus (VZV) infections like chickenpox and shingles. The drug works by inhibiting viral DNA replication, thus curbing the spread of the virus within the body. Aciclovir is available in various formulations, including oral tablets, intravenous injections, and topical creams. For recurrent herpes simplex infections, oral aciclovir is often prescribed to reduce the frequency and severity of outbreaks. In severe cases, particularly in immunocompromised individuals, intravenous aciclovir may be administered for more effective control of the viral infection. Additionally, topical aciclovir creams are commonly used to alleviate symptoms and promote faster healing of herpes lesions. While generally well-tolerated, aciclovir may cause side effects such as nausea, headache, and dizziness. Long-term use may also lead to the development of drug-resistant strains of the virus. Regular monitoring, dosage adjustments, and careful consideration of patient factors are crucial in optimizing the efficacy and safety of aciclovir therapy.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States